Home > Boards > US OTC > Miscellaneous >

Axim Biotechnologies Inc. (AXIM)

Add AXIM Price Alert      Hide Sticky   Hide Intro
Moderator: Blue Skys
Search This Board: 
Last Post: 2/26/2021 3:29:42 PM - Followers: 99 - Board type: Free - Posts Today: 7

News updates July 23rd 2020
"The NeuCovix™ test was compared to a gold standard pseudovirus-based test. NeuCovix™ accurately classified serum from patients who strongly neutralized SARS-CoV-2 and serum from patients who poorly neutralized the virus. Additionally, NeuCovix™ did not cross-react with serum from patients with seasonal respiratory infections including seasonal coronaviruses, suggesting that the test has 100 percent specificity for COVID-19. 


July 15, 2020 08:30 ET Source: AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, July 15, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological research, today announced the development of NeuCovixTM, a rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.

Unlike currently available serological COVID-19 tests that detect an antibody response to the virus, AXIM’s rapid 10-minute test measures a specific subpopulation of antibodies to block binding of the virus to host cell receptors. While there are expensive, time consuming laboratory tests that measure neutralizing antibodies, NeuCovixTM differs in that it is a portable, low cost, rapid point-of-care test with results in 10 minutes.

“We are hopeful our test fills an important need in these uncertain times. While other tests merely show whether someone was infected with coronavirus, we took it a step further by creating a test that stratifies individuals into those who have neutralizing antibodies, which are essential in preventing reinfection, and those who don’t. The test can be deployed for point of care use in convalescent plasma transfusions to severely ill patients and for evaluating efficacy of upcoming vaccines in generating protective antibodies,” said Sergei Svarovsky, PhD, MBA, AXIM’s CSO and co-inventor of NeuCovixTM.

An immediate application of NeuCovixTM, a point-of-care test, is to measure levels of neutralizing antibodies in convalescent plasma so that plasma with the highest levels of neutralizing antibodies can be identified and administered to patients fighting COVID-19.  Without this knowledge, many patients could be undertreated with non-neutralizing plasma and may not benefit from this treatment. 

Another application of NeuCovixTM is to help ensure that vaccines elicit high levels of neutralizing antibodies. When a vaccine is available, manufacturers can employ the NeuCovixTM rapid, point-of-care test to evaluate protective immune responses in vaccine recipients.

AXIM® Biotech CEO John W. Huemoeller II commented, Our goal was to make this test, accurate, fast and relatively inexpensive so it could serve as an ‘Immunity Passport port™’ for vaccine developers around the world as they begin larger Phase II and III clinical trials. We are optimistic that NeuCovixTM will be widely used, becoming the gold standard in assessing levels of immunity.

Doug Lake, Ph.D. and co-inventor of NeuCovixTM commented, “Everybody who recovers from COVID-19 makes antibodies against the virus, but since all antibodies are not created equal, you really want to know if the antibodies you make neutralize the virus. People who recover want to make sure they are protected from re-infection and that they won’t infect others.”

AXIM also announced the filing of a pre-Emergency Use Authorization Application (EUA) and has already initiated dialogue with the FDA in order to finalize its EUA submission. The intellectual property relating to the novel serological test is the subject of Provisional Patent Application No. 63/023,646 “Convalescent Plasma Testing and Treatment” filed on May 12, 2020. 

About AXIM® Biotechnologies
Founded in 2014, AXIM® Biotechnologies, Inc. (AXIM) is a vertically integrated oncology company developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis. The Company is also developing novel antibodies for therapeutic and diagnostic uses for oncological therapeutics. For more information, please visit www.AXIMBiotech.com.



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#1478   Completely non sequitur to the previous posts. And RipperMagoo1 02/26/21 03:29:42 PM
#1477   Its an immaterial fact that is employed to Blue Skys 02/26/21 03:14:51 PM
#1476   My posts are not a knock on Barry RipperMagoo1 02/26/21 02:43:29 PM
#1475   If anyone thinks that Barry at Empowered Diagnostics Blue Skys 02/26/21 02:11:06 PM
#1474   Dean, I wish they were real too but RipperMagoo1 02/26/21 12:47:45 PM
#1473   What ever you say. Can't just be the Dean14 02/26/21 09:09:00 AM
#1472   Common (gray hat) online marketing tactic to increase RipperMagoo1 02/26/21 02:16:11 AM
#1471   Code1supply has orders popping on the screen Watch Dean14 02/25/21 09:13:06 AM
#1470   AXIM...64..."W" Pattern in play here with a Resistance georgie18 02/24/21 05:02:20 AM
#1469   Thanks for the web address. It will scoobey-do 02/23/21 12:10:35 PM
#1468   Were almost there. https://www.code1supply.com/immunopass-covid-19-rapid-neutra Dean14 02/23/21 11:38:07 AM
#1467   AXIM...60...Took a starter here...:party: georgie18 02/23/21 10:08:21 AM
#1466   Great. Looks like the Mayo Clinic helped Blue Skys 02/22/21 02:58:58 AM
#1465   The Stage is set. Start up the Band. Dean14 02/21/21 08:55:01 AM
#1464   Is she going to sing? scoobey-do 02/21/21 07:39:07 AM
#1463   Never mind I got it now. baldingcontrarian 02/20/21 04:02:47 PM
#1462   What paper do you speak of? baldingcontrarian 02/20/21 02:42:17 PM
#1461   The ingredients for a big long run on Blue Skys 02/19/21 10:20:40 PM
#1460   Massive run coming any day now. $AXIM jjr04001 02/19/21 08:09:22 PM
#1459   My targets are much higher than those numbers Blue Skys 02/19/21 03:10:06 PM
#1458   Well it does have targets of 1.63, 1.84, trickybiz 02/16/21 01:31:57 AM
#1457   Empdx dot N E T baldingcontrarian 02/12/21 01:48:01 PM
#1456   Product is for sale on empowered diagnostics . baldingcontrarian 02/12/21 01:47:15 PM
#1455   Why the spike today!? CAN8IENS 02/12/21 01:13:15 PM
#1454   Getting the feeling were gonna Blow out the Dean14 02/12/21 01:04:00 PM
#1453   Besides making a tangible and significant contribution to society, baldingcontrarian 02/12/21 05:42:15 AM
#1452   That's great DD. I had forgotten that Blue Skys 02/10/21 07:17:18 PM
#1451   Does this news relate to Axim's test?: nilremerlin 02/09/21 02:51:41 PM
#1450   AXIM CC says royalty will be around Dean14 02/07/21 01:35:15 PM
#1449   Also need help getting stock baldingcontrarian 02/07/21 07:09:54 AM
#1448   Given the data before us, baldingcontrarian 02/06/21 10:25:14 PM
#1447   https://empdx.net/immunopass-antibody-test/ Midnightmatt 02/06/21 07:28:43 PM
#1446   Sales went live today on empowereds web site baldingcontrarian 02/06/21 02:09:02 AM
#1445   Come on baby, daddy's almost even LOL CAN8IENS 02/05/21 12:37:58 PM
#1444   This stock is gold. ScooterTime022 02/05/21 10:19:17 AM
#1443   Interesting field of research and room on that chart 12yearplan 02/04/21 05:25:57 AM
#1442   AXIM was picked today on the close for cottonmather 02/03/21 07:43:49 PM
#1441   AXIM(R) Biotechnologies Begins Clinical Trials on Its ImmunoPass Dean14 02/03/21 09:11:34 AM
#1440   Immuno Pass Available February 2021 https://empdx.net/ Dean14 02/01/21 01:32:33 PM
#1439   The pump and dump happened this summer. Blue Skys 01/31/21 02:11:17 PM
#1438   Perhaps AXIM could be mentioned on the Reddit BesaoT35 01/29/21 04:08:48 PM
#1437   What if Immunopass were to become a standard BesaoT35 01/28/21 03:50:41 PM
#1436   https://empdx.net/immunopass-antibody-test/ Dean14 01/27/21 09:12:53 AM
#1435   Does this company ever post any news? Stradle 01/26/21 03:12:51 PM
#1434   I'm glad that you are feeling great but Blue Skys 01/21/21 04:08:36 PM
#1433   Bought 10,000 at .45 and feeling great Stradle 01/21/21 10:15:34 AM
#1432   I am thinking of lowering my offer from Stradle 01/19/21 02:53:53 PM
#1431   I’m not sure why they released a summary baldingcontrarian 01/16/21 07:01:50 AM
#1430   AXIM has potential but stumbles and cannot seem smoking guns 01/15/21 03:39:27 PM
#1429   Only if they get EUA...Im watching mc73 01/13/21 11:17:05 AM
Consent Preferences